Rajan Anand

This inventor holds 21 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 17 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Merck Sharp + Dohme Corp., Incyte Corporation, Merck Sharp + Dohme B.v.. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajan Anand. Retrieved from https://idiyas.com/inventor/rajan-anand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 17 (Patent Applications = 6)

Average Co-Inventor Count = 10.7

ph-index = 4

Forward Citations = 39(Granted Patents)

Location History:

Wilmington, DE (US) (2007 - 2015)
Westfield, NJ (US) (2015)
Fanwood, NJ (US) (2014 - 2021)

Company Filing History:

16 out of 2,405

Merck Sharp + Dohme Corp.

Merck Sharp + Dohme B.v.

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Cytotoxic Agents

Voltage-Gated Sodium Channels

BTK Inhibitors

Anti-Diabetic Agents

Chemokine Receptors

Aminoquinazoline Compounds

Aryl Sulfonamide Compounds

Cyclohexylglycine Derivatives

Indole Derivatives

Diamine Compounds

Piperazinylpiperidine Derivatives

Benzamide Compounds

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12310945 - Cyclohexylglycine derivatives as selective cytotoxic agents (2025-05-27),

2. 10968210 - Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels (2021-04-06),

3. 10822338 - Substituted aminoquinazoline compounds as Aantagonist (2020-11-03),

4. 10519147 - Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels (2019-12-31),

5. 10246457 - Indazole and azaindazole Btk inhibitors (2019-04-02),

6. 10221167 - Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels (2019-03-05),

7. 10130630 - BTK inhibitors (2018-11-20),

8. 10093683 - Factor XIa inhibitors (2018-10-09),

9. 9718828 - BTK Inhibitors (2017-08-01),

10. 9676780 - [object Object] (2017-06-13),

11. 9650375 - Indole derivatives useful as anti-diabetic agents (2017-05-16),

12. 9637486 - Btk inhibitors (2017-05-02),

13. 9481682 - Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors (2016-11-01),

14. 9126976 - Substituted benzopiperazines as CETP inhibitors (2015-09-08),

15. 9067921 - Piperazinylpiperidine derivatives as chemokine receptor antagonists (2015-06-30),

Title: The Innovative Journey of Rajan Anand

Introduction: Rajan Anand, a talented inventor hailing from Fanwood, NJ (US), has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Rajan Anand holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing new solutions to complex problems.

Career Highlights: Throughout his career, Rajan Anand has demonstrated a remarkable ability to innovate and create novel technologies that have had a lasting impact on the industry. His dedication to pushing the boundaries of what is possible has earned him recognition as a visionary inventor.

Collaborations: Rajan Anand has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Rajan Anand's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire future generations of inventors to think outside the box and strive for greatness in their pursuits.

Profile summary based on public USPTO records.